 |
|
Comments - Posted 30 June 2009
Read remarks by Donna Wilcock about Puzzo D et al.
PAPER: Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model.
Comments - Posted 30 June 2009
Read remarks by Michael Vitek, David A. Wink, Carol Colton about Puzzo D et al.
PAPER: Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model.
Comments - Posted 30 June 2009
Read remarks by Thomas Beach about Beach TG et al.
PAPER: Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.
Comments - Posted 30 June 2009
Read remarks by Steve Barger about
Matrone C et al.
NEWS: From Trophic to Toxic—Aβ Corrupts the NGF Receptor?
Comments - Posted 29 June 2009
Read remarks by Frederic Calon about He C et al.
PAPER: Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid.
Comments - Posted 29 June 2009
Read remarks by Gregory Cole about He C et al.
PAPER: Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid.
Desperately Seeking Antibodies - Posted 18 November 2008
A request for some Alz-50 or MC1 antibody. "I am just finishing my PhD and would love to look at confirmational changes in relationship to other AD pathology in human tissue."
A question about the amyloid-beta antibody 4G8, from Rufus Akinyemi: How specific is 4G8 for insoluble amyloid fibrils in amyloid plaques? I'm getting significant intracellular IR (suggesting intracellular amyloid presence) while using 4G8 to stain f! or extracellular amyloid.
|
|
|
|
|
|
Home
